The previous analysis revealed that a large portion of Medicare Part D spending was concentrated in a small number of drugs. Among all drug classes, GLP-1 agonists emerged as a clear winner. In this post, we will examine the contribution of GLP-1 drugs to Medicare Part D spending over the years (2019-2023).
(more…)-
Top 10 Medicare Part D Drugs Over the Years (2019-2023)
In the previous post, we discussed how Medicare Part D spending increased by 48% from 2019 to 2023. We noticed that a small number of drugs accounted for a large share of total expenditures. This leads us to wonder which drugs are the primary leaders of the spending growth. Were all of these drugs consistent over the five years?
In this blog post, we will explore the drugs that made it onto the top ten list over the years and how their growth changed with time.
(more…) -
What are the Factors Driving Medicare Part D Spending (2019-2023)?
Medicare Part D spending increased from approximately $220 billion in 2019 to $326 billion over five years (2019-2023). It’s a significant increase of approximately 48%. In this post, we will explore the possible causes behind the increasing expenditure.
(more…) -
Changing Trends in Medicare Part D Spending (2019–2023)
Medicare Part D aims to provide financial assistance to people, enabling them to buy prescribed drugs at reduced cost. It is available to people who are already part of the Medicare program. This drug coverage program effectively reduces the financial burden on the public.
The following post is an analysis of publicly available Medicare Part D data for the years 2019-2023. It may seem outdated as we are currently in 2026. However, data collection and recordkeeping usually take years to complete. So, the data used for analysis is the latest available record published by the Centers for Medicare and Medicaid Services(CMS) on its official website.
(more…)